Tag: Laminate Medical
Delcath Systems announce first commercial use of Hepzato Kit
Delcath Systems, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, has announced the first commercial use...
Laminate Medical announces first implantation of VasQ AVF device
Laminate Medical has announced the first implantation of their VasQ device in the USA, performed by Ari Kramer (Spartanburg Regional Hospital, Spartanburg, USA). The...
Largest real-world experience to date with VasQ device indicates long-term benefits...
The VasQ external support device (Laminate Medical) has demonstrated long-term benefits for radiocephalic (forearm) arteriovenous fistula (AVF) creation in a retrospective analysis of 150...
VasQ external support awarded NUB Status 1 reimbursement renewal for 2021...
The German Institute for Hospital Remuneration (InEK) has renewed the new examination and treatment methods (NUB) Status 1 designation of VasQ external support (Laminate...
VasQ external support awarded breakthrough device designation by the FDA
The US Food and Drug Administration (FDA) has designated Laminate Medical’s VasQ external support for the creation of arteriovenous fistulas (AVF) in haemodialysis patients...
Published real-world experience demonstrates VasQ External Support improves outcomes when adopted...
Robert Shahverdyan, head of the Vascular Access Center at Asklepios Klinik Barmbek, Hamburg, Germany, has recently published a retrospective analysis of his first 32...
Enrolment of the VasQ external support US pivotal study now complete
Laminate Medical Technologies has announced the completion of enrolment into the VasQ external support US pivotal study. The study was conducted at 17 sites...
